Please schedule a consultation with our doctor before each new injection
First Consultation by Doctor
If Mounjaro is deemed unsuitable for use, a consultation fee of $400 will be charged.
Second assessment
After the body check-up and assessment by the doctor confirm suitability:
Together, we will identify your appropriate goals and start the first injection. Use one dose weekly, with a starting dosage of 2.5 mg, and please follow the dosage recommended by your doctor.
Third assessment
Within a week after the fourth injection, please inform your doctor about your response to the current dosage, and the doctor will make adjustments based on your feedback.
Physical Examination
BP/ Pulse / Weight / Height / BMI
Lipid + Hypertension + Diabetes Mellitus Profile check up
Total Cholesterol
HDL Cholesterol
LDL Cholesterol
Triglycerides
Cholesterol HDL Ratio
Urea
Creatinine
Sodium
Potassium
Uric Acid
HbA1c
Fasting Glucose
SGPT/ALT
FibroTouch®
Evaluation of fatty liver and liver fibrosis
What is Mounjaro®滿健樂?
Mounjaro®滿健樂 is a medication used to treat type 2 diabetes, with the active ingredient being tirzepatide.
Who is Suitable for Using Mounjaro®滿健樂?
- Patients with Type 2 Diabetes: Especially those who cannot control their blood sugar through diet and exercise.
- Patients Needing Weight Loss: Many type 2 diabetes patients also face issues of being overweight or obese, and Mounjaro's effectiveness in weight loss is particularly important for these patients.
- Patients Not Benefiting from Other Treatments: For those who are unable to achieve blood sugar control goals despite using other diabetes medications (such as oral medications or insulin).
- Patients Seeking Overall Health Improvement: Some patients wish to improve their overall health by controlling blood sugar and losing weight.
Who are unsuitable for using Mounjaro®?
- BMI below 27
- BMI between 27 and 30 without issues related to the "three highs" (hypertension, diabetes, and high cholesterol)
- Patients with type 1 diabetes
- History of pancreatitis
- Pregnant women, those planning to become pregnant, or breastfeeding (safety not established)
- Individuals with liver or kidney dysfunction
- Patients with severe gastrointestinal diseases or those who have undergone gastrointestinal surgery
- Individuals with thyroid cancer or a family history of it
- Individuals with endocrine cancers or a family history of them
- Diabetic retinopathy or macular degeneration
- Allergies to the medication's ingredients
How to Choose the Dosage?
Mounjaro®滿健樂 has multiple dosage options. Please schedule a consultation with a doctor to determine the appropriate dosage for you. The starting dosage is 2.5 mg once a week. During your follow-up visit, let your doctor know how you respond to the current dosage, and the doctor will make adjustments based on your response.
How to Use Mounjaro®滿健樂?
(For detailed usage instructions, please refer to the image.)
Mounjaro®滿健樂 is administered once a week, following the dosage recommended by your doctor. It is a subcutaneous injection, and the best injection sites are the front side of the abdomen, the outer thigh, or the upper arm.
What if You Forget to Inject Mounjaro®滿健樂?
If you forget to inject, and it is within four days of when you were supposed to inject, please inject immediately and continue with your next scheduled dose as usual. If it has been more than four days since your scheduled injection, skip the missed dose and proceed with your next scheduled dose. Do not use double the dosage to make up for a missed injection. Do not stop using Mounjaro®滿健樂 without discussing it with your doctor.
Precautions and Common Side Effects of Mounjaro®滿健樂?
The most common side effects of Mounjaro®滿健樂 are gastrointestinal discomfort, including nausea, bloating, constipation, and vomiting. These side effects are most likely to occur when the dosage is increased, and they are usually not severe. They are most common when first starting the medication, and most patients will experience a gradual reduction in side effects.
If you have any questions, please contact us.
